NS-051/NCNP-04

N/A

Report date: 2025/10/10 15:37:21
NME

Base Information

Drug NameNS-051/NCNP-04
Drug Alias NameNS-051/NCNP-04
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionDystrophin stimulants
TargetsDystrophin
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Center Of Neurology And PsychiatryNippon Shinyaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNippon Shinyaku Co Ltd
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A